Anti-ischemia/reperfusion of C1 inhibitor in myocardial cell injury via regulation of local myocardial C3 activity
- 1 November 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 350 (1) , 162-168
- https://doi.org/10.1016/j.bbrc.2006.09.023
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Preventing Renal IschemiaReperfusion Injury Using Small Interfering RNA by Targeting Complement 3 GeneAmerican Journal of Transplantation, 2006
- C1‐Inhibitor Reduces the Ischaemia–Reperfusion Injury of Skeletal Muscles in Mice after Aortic Cross‐ClampingScandinavian Journal of Immunology, 2002
- Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarctionEuropean Heart Journal, 2002
- C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical applicationMolecular Immunology, 1999
- ANTI-SELECTIN THERAPY MODIFIES SKELETAL MUSCLE ISCHEMIA AND REPERFUSION INJURYShock, 1996
- Myocardial infarct extension during reperfusion after coronary artery occlusion: Pathologic evidenceJournal of the American College of Cardiology, 1993
- Reperfusion induced injury: manifestations, mechanisms, and clinical relevanceCardiovascular Research, 1992
- The role of C3 in the immune responseImmunology Today, 1991
- The role of complement in inflammation and phagocytosisImmunology Today, 1991
- Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and NecrosisScience, 1990